{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:25:09Z","timestamp":1775503509877,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10528-025-11077-4","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:58:03Z","timestamp":1741755483000},"page":"1161-1173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of HLA-DRA, HLA-DQA1 and IL-6 Gene Variations to Glatiramer Acetate Resistance in Multiple Sclerosis Patients"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-6778","authenticated-orcid":false,"given":"Aysegul","family":"Sahbaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2363-7568","authenticated-orcid":false,"given":"Busranur Oguz","family":"Selcuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-7101","authenticated-orcid":false,"given":"Fusun Mayda","family":"Domac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4395-5141","authenticated-orcid":false,"given":"Serkan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-0064","authenticated-orcid":false,"given":"Mesrure","family":"Koseoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0535-1364","authenticated-orcid":false,"given":"Ebru Hatun","family":"Uludasdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-5652","authenticated-orcid":false,"given":"Gulsah","family":"Koc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-6535","authenticated-orcid":false,"given":"Bayram","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-7344","authenticated-orcid":false,"given":"Deniz","family":"Kirac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"issue":"1","key":"11077_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029819","volume":"7","author":"A Alcina","year":"2012","unstructured":"Alcina A, Abad-Grau Mdel M, Fedetz M, Izquierdo G, Lucas M, Fern\u00e1ndez O, Ndagire D, Catal\u00e1-Rabasa A, Ruiz A, Gay\u00e1n J, Delgado C, Arnal C, Matesanz F (2012) Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations. PLoS ONE 7(1):e29819. https:\/\/doi.org\/10.1371\/journal.pone.0029819","journal-title":"PLoS ONE"},{"issue":"12 Suppl","key":"11077_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1586\/14737175.2013.865866","volume":"13","author":"A Ascherio","year":"2013","unstructured":"Ascherio A (2013) Environmental factors in multiple sclerosis. Expert Rev Neurother 13(12 Suppl):3\u20139. https:\/\/doi.org\/10.1586\/14737175.2013.865866","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"11077_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61(4):288\u2013299. https:\/\/doi.org\/10.1002\/ana.21117","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"11077_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2012.10.014","volume":"255","author":"Y Bene\u0161ov\u00e1","year":"2013","unstructured":"Bene\u0161ov\u00e1 Y, Va\u0161k\u016f A, Stoura\u010d P, Hlad\u00edkov\u00e1 M, Fiala A, Bedna\u0159\u00edk J (2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J Neuroimmunol 255(1\u20132):92\u201396. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.10.014","journal-title":"J Neuroimmunol"},{"issue":"3","key":"11077_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13760-018-0994-9","volume":"118","author":"Y Bene\u0161ov\u00e1","year":"2018","unstructured":"Bene\u0161ov\u00e1 Y, Va\u0161k\u016f A, Bienertov\u00e1-Va\u0161k\u016f J (2018) Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis. Acta Neurol Belg 118(3):493\u2013501. https:\/\/doi.org\/10.1007\/s13760-018-0994-9","journal-title":"Acta Neurol Belg"},{"issue":"6578","key":"11077_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375(6578):296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222","journal-title":"Science"},{"issue":"11","key":"11077_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","volume":"83","author":"P Browne","year":"2014","unstructured":"Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, Thompson AJ (2014) Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity. Neurology 83(11):1022\u20131024. https:\/\/doi.org\/10.1212\/WNL.0000000000000768","journal-title":"Neurology"},{"issue":"Pt 10","key":"11077_CR8","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C, Rinaldi F, Perini P, Gallo P (2012) Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135(Pt 10):2952\u20132961. https:\/\/doi.org\/10.1093\/brain\/aws246","journal-title":"Brain"},{"issue":"6","key":"11077_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011296","volume":"5","author":"BA Cree","year":"2010","unstructured":"Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, Sawcer SJ, Oksenberg JR, Hauser SL, IMAGEN; IMSGC (2010) A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS ONE 5(6):e11296. https:\/\/doi.org\/10.1371\/journal.pone.0011296","journal-title":"PLoS ONE"},{"issue":"1","key":"11077_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis\u2014a review. Eur J Neurol 26(1):27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"issue":"3","key":"11077_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","volume":"7","author":"GC Ebers","year":"2008","unstructured":"Ebers GC (2008) Environmental factors and multiple sclerosis. Lancet Neurol 7(3):268\u2013277. https:\/\/doi.org\/10.1016\/S1474-4422(08)70042-5","journal-title":"Lancet Neurol"},{"issue":"8","key":"11077_CR12","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2018.0611","volume":"75","author":"E Evans","year":"2018","unstructured":"Evans E, Piccio L, Cross AH (2018) Use of vitamins and dietary supplements by patients with multiple sclerosis: a review. JAMA Neurol 75(8):1013\u20131021. https:\/\/doi.org\/10.1001\/jamaneurol.2018.0611","journal-title":"JAMA Neurol"},{"issue":"1","key":"11077_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00439-012-1223-x","volume":"132","author":"N Falah","year":"2013","unstructured":"Falah N, McElroy J, Snegovskikh V, Lockwood CJ, Norwitz E, Murray JC, Kuczynski E, Menon R, Teramo K, Muglia LJ, Morgan T (2013) Investigation of genetic risk factors for chronic adult diseases for association with preterm birth. Hum Genet 132(1):57\u201367. https:\/\/doi.org\/10.1007\/s00439-012-1223-x","journal-title":"Hum Genet"},{"issue":"3","key":"11077_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/1352458509358088","volume":"16","author":"C Ford","year":"2010","unstructured":"Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinsky J (2010) Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler 16(3):342\u2013350. https:\/\/doi.org\/10.1177\/1352458509358088","journal-title":"Mult Scler"},{"issue":"4","key":"11077_CR15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","volume":"20","author":"H Ford","year":"2020","unstructured":"Ford H (2020) Clinical presentation and diagnosis of multiple sclerosis. Clin Med (Lond) 20(4):380\u2013383. https:\/\/doi.org\/10.7861\/clinmed.2020-0292","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"11077_CR16","first-page":"175","volume":"37","author":"MM Goldenberg","year":"2012","unstructured":"Goldenberg MM (2012) Multiple sclerosis review. PT 37(3):175\u2013184","journal-title":"PT"},{"key":"11077_CR17","doi-asserted-by":"publisher","first-page":"1255533","DOI":"10.3389\/fimmu.2023.1255533","volume":"14","author":"E Grebenciucova","year":"2023","unstructured":"Grebenciucova E, VanHaerents S (2023) Interleukin 6: at the interface of human health and disease. Front Immunol 14:1255533. https:\/\/doi.org\/10.3389\/fimmu.2023.1255533","journal-title":"Front Immunol"},{"issue":"9","key":"11077_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012496","volume":"5","author":"AE Handel","year":"2010","unstructured":"Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV (2010) An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE 5(9):e12496. https:\/\/doi.org\/10.1371\/journal.pone.0012496","journal-title":"PLoS ONE"},{"issue":"5","key":"11077_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102512","volume":"19","author":"H Inojosa","year":"2020","unstructured":"Inojosa H, Schriefer D, Ziemssen T (2020) Clinical outcome measures in multiple sclerosis: a review. Autoimmun Rev 19(5):102512. https:\/\/doi.org\/10.1016\/j.autrev.2020.102512","journal-title":"Autoimmun Rev"},{"key":"11077_CR20","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/nyas.12821","volume":"1351","author":"K Janssens","year":"2015","unstructured":"Janssens K, Slaets H, Hellings N (2015) Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis. Ann N Y Acad Sci 1351:52\u201360. https:\/\/doi.org\/10.1111\/nyas.12821","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"11077_CR21","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1212\/wnl.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The copolymer 1 multiple sclerosis study group. Neurology 45(7):1268\u20131276. https:\/\/doi.org\/10.1212\/wnl.45.7.1268","journal-title":"Neurology"},{"issue":"1","key":"11077_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2015.01.022","volume":"108","author":"AK Kiani","year":"2015","unstructured":"Kiani AK, John P, Bhatti A, Zia A, Shahid G, Akhtar P, Wang X, Demirci FY, Kamboh MI (2015) Association of 32 type 1 diabetes risk loci in Pakistani patients. Diabetes Res Clin Pract 108(1):137\u2013142. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.022","journal-title":"Diabetes Res Clin Pract"},{"key":"11077_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.msard.2019.01.033","volume":"29","author":"I Kiselev","year":"2019","unstructured":"Kiselev I, Bashinskaya V, Baulina N, Kozin M, Popova E, Boyko A, Favorova O, Kulakova O (2019) Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: the impact of immune-related genes variability. Mult Scler Relat Disord 29:130\u2013136. https:\/\/doi.org\/10.1016\/j.msard.2019.01.033","journal-title":"Mult Scler Relat Disord"},{"issue":"8","key":"11077_CR24","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/1352458517694432","volume":"23","author":"G Kobelt","year":"2017","unstructured":"Kobelt G, Thompson A, Berg J, Gannedahl M, Eriksson J, MSCOI Study Group, European Multiple Sclerosis Platform (2017) New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler 23(8):1123\u20131136. https:\/\/doi.org\/10.1177\/1352458517694432","journal-title":"Mult Scler"},{"issue":"5","key":"11077_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen N, S\u00f8rensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9(5):520\u2013532. https:\/\/doi.org\/10.1016\/S1474-4422(10)70064-8","journal-title":"Lancet Neurol"},{"issue":"8","key":"11077_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/wnl.5.8.580","volume":"5","author":"JF Kurtzke","year":"1955","unstructured":"Kurtzke JF (1955) A new scale for evaluating disability in multiple sclerosis. Neurology 5(8):580\u2013583. https:\/\/doi.org\/10.1212\/wnl.5.8.580","journal-title":"Neurology"},{"issue":"11","key":"11077_CR27","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/wnl.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452. https:\/\/doi.org\/10.1212\/wnl.33.11.1444","journal-title":"Neurology"},{"issue":"5","key":"11077_CR28","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/wnl.35.5.672","volume":"35","author":"JF Kurtzke","year":"1985","unstructured":"Kurtzke JF, Beebe GW, Norman JE Jr (1985) Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology 35(5):672\u2013678. https:\/\/doi.org\/10.1212\/wnl.35.5.672","journal-title":"Neurology"},{"issue":"12","key":"11077_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.autrev.2013.10.012","volume":"13","author":"S Mahurkar","year":"2014","unstructured":"Mahurkar S, Suppiah V, O\u2019Doherty C (2014) Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature. Autoimmun Rev 13(12):1243. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.012","journal-title":"Autoimmun Rev"},{"key":"11077_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102104","volume":"25","author":"R McKinley","year":"2020","unstructured":"McKinley R, Wepfer R, Grunder L, Aschwanden F, Fischer T, Friedli C, Muri R, Rummel C, Verma R, Weisstanner C, Wiestler B, Berger C, Eichinger P, Muhlau M, Reyes M, Salmen A, Chan A, Wiest R, Wagner F (2020) Automatic detection of lesion load change in multiple sclerosis using convolutional neural networks with segmentation confidence. Neuroimage Clin 25:102104. https:\/\/doi.org\/10.1016\/j.nicl.2019.102104","journal-title":"Neuroimage Clin"},{"issue":"1\u20132","key":"11077_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2011.04.014","volume":"236","author":"D Mirowska-Guzel","year":"2011","unstructured":"Mirowska-Guzel D, Gromadzka G, Mach A, Czlonkowski A, Czlonkowska A (2011) Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-\u03b1 polymorphisms with risk and clinical course of multiple sclerosis in a polish population. J Neuroimmunol 236(1\u20132):87\u201392. https:\/\/doi.org\/10.1016\/j.jneuroim.2011.04.014","journal-title":"J Neuroimmunol"},{"issue":"6","key":"11077_CR32","doi-asserted-by":"publisher","first-page":"e1002053","DOI":"10.1371\/journal.pmed.1002053","volume":"13","author":"LE Mokry","year":"2016","unstructured":"Mokry LE, Ross S, Timpson NJ, Sawcer S, Davey Smith G, Richards JB (2016) Obesity and multiple sclerosis: a mendelian randomization study. PLoS Med 13(6):e1002053. https:\/\/doi.org\/10.1371\/journal.pmed.1002053","journal-title":"PLoS Med"},{"issue":"4","key":"11077_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<322::AID-JNR1>3.0.CO;2-B","volume":"45","author":"V Navikas","year":"1996","unstructured":"Navikas V, Link H (1996) Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 45(4):322\u2013333","journal-title":"J Neurosci Res"},{"issue":"1","key":"11077_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7762\/cnr.2019.8.1.36","volume":"8","author":"E Nozari","year":"2019","unstructured":"Nozari E, Ghavamzadeh S, Razazian N (2019) The effect of vitamin B12 and folic acid supplementation on serum homocysteine, anemia status and quality of life of patients with multiple sclerosis. Clin Nutr Res 8(1):36\u201345. https:\/\/doi.org\/10.7762\/cnr.2019.8.1.36","journal-title":"Clin Nutr Res"},{"issue":"9","key":"11077_CR35","doi-asserted-by":"publisher","first-page":"11718","DOI":"10.3390\/ijms130911718","volume":"13","author":"C O\u2019Gorman","year":"2012","unstructured":"O\u2019Gorman C, Lucas R, Taylor B (2012) Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 13(9):11718\u201311752. https:\/\/doi.org\/10.3390\/ijms130911718","journal-title":"Int J Mol Sci"},{"issue":"11","key":"11077_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","volume":"5","author":"SM Orton","year":"2006","unstructured":"Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5(11):932\u2013936. https:\/\/doi.org\/10.1016\/S1474-4422(06)70581-6","journal-title":"Lancet Neurol"},{"issue":"2","key":"11077_CR37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1352458512449682","volume":"19","author":"J Pakpoor","year":"2013","unstructured":"Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV (2013) The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis. Mult Scler 19(2):162\u2013166. https:\/\/doi.org\/10.1177\/1352458512449682","journal-title":"Mult Scler"},{"issue":"9","key":"11077_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139197","volume":"10","author":"A Paziewska","year":"2015","unstructured":"Paziewska A, Cukrowska B, Dabrowska M, Goryca K, Piatkowska M, Kluska A, Mikula M, Karczmarski J, Oralewska B, Rybak A, Socha J, Balabas A, Zeber-Lubecka N, Ambrozkiewicz F, Konopka E, Trojanowska I, Zagroba M, Szperl M, Ostrowski J (2015) Combination testing using a single MSH5 variant alongside HLA haplotypes improves the sensitivity of predicting coeliac disease risk in the polish population. PLoS ONE 10(9):e0139197. https:\/\/doi.org\/10.1371\/journal.pone.0139197","journal-title":"PLoS ONE"},{"issue":"2","key":"11077_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O\u2019Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"1","key":"11077_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/13816810.2020.1839916","volume":"42","author":"V Punyte","year":"2021","unstructured":"Punyte V, Vilkeviciute A, Gedvilaite G, Kriauciuniene L, Liutkeviciene R (2021) Association of VEGFA, TIMP-3, and IL-6 gene polymorphisms with predisposition to optic neuritis and optic neuritis with multiple sclerosis. Ophthalmic Genet 42(1):35\u201344. https:\/\/doi.org\/10.1080\/13816810.2020.1839916","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"11077_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/archneur.1992.00530300089014","volume":"49","author":"EH Reynolds","year":"1992","unstructured":"Reynolds EH, Bottiglieri T, Laundy M, Crellin RF, Kirker SG (1992) Vitamin B12 metabolism in multiple sclerosis. Arch Neurol 49(6):649\u2013652. https:\/\/doi.org\/10.1001\/archneur.1992.00530300089014","journal-title":"Arch Neurol"},{"issue":"8","key":"11077_CR42","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archneur.1991.00530200044017","volume":"48","author":"EH Reynolds","year":"1991","unstructured":"Reynolds EH, Linnell JC, Faludy JE (1991) Multiple sclerosis associated with vitamin B12 deficiency. Arch Neurol 48(8):808\u2013811. https:\/\/doi.org\/10.1001\/archneur.1991.00530200044017","journal-title":"Arch Neurol"},{"issue":"1\u20134","key":"11077_CR43","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/00207459309000596","volume":"71","author":"R Sandyk","year":"1993","unstructured":"Sandyk R, Awerbuch GI (1993) Vitamin B12 and its relationship to age of onset of multiple sclerosis. Int J Neurosci 71(1\u20134):93\u201399. https:\/\/doi.org\/10.3109\/00207459309000596","journal-title":"Int J Neurosci"},{"key":"11077_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2015.04.020","volume":"298","author":"G Scalabrino","year":"2015","unstructured":"Scalabrino G, Veber D, De Giuseppe R, Roncaroli F (2015) Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord. Neuroscience 298:293\u2013301. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.04.020","journal-title":"Neuroscience"},{"issue":"1","key":"11077_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.smim.2013.11.002","volume":"26","author":"J Scheller","year":"2014","unstructured":"Scheller J, Garbers C, Rose-John S (2014) Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin Immunol 26(1):2\u201312. https:\/\/doi.org\/10.1016\/j.smim.2013.11.002","journal-title":"Semin Immunol"},{"issue":"1","key":"11077_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","volume":"7","author":"MB Sintzel","year":"2018","unstructured":"Sintzel MB, Rametta M, Reder AT (2018) Vitamin D and multiple sclerosis: a comprehensive review. Neurol Ther 7(1):59\u201385. https:\/\/doi.org\/10.1007\/s40120-017-0086-4","journal-title":"Neurol Ther"},{"issue":"4","key":"11077_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/13816810.2020.1768555","volume":"41","author":"V Stonys","year":"2020","unstructured":"Stonys V, Lind\u017ei\u016bt\u0117 M, Vilkevi\u010di\u016bt\u0117 A, Gedvilait\u0117 G, Kriau\u010di\u016bnien\u0117 L, Banevi\u010dius M, \u017demaitien\u0117 R, Liutkevi\u010dien\u0117 R (2020) Associations between IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, and HTRA1 rs11200638 gene polymorphisms and development of optic neuritis with or without multiple sclerosis. Ophthalmic Genet 41(4):325\u2013330. https:\/\/doi.org\/10.1080\/13816810.2020.1768555","journal-title":"Ophthalmic Genet"},{"issue":"6","key":"11077_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1468-1331.2008.02122.x","volume":"15","author":"P Sundstr\u00f6m","year":"2008","unstructured":"Sundstr\u00f6m P, Nystr\u00f6m L, Hallmans G (2008) Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15(6):579\u2013583. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02122.x","journal-title":"Eur J Neurol"},{"issue":"6","key":"11077_CR49","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H","volume":"47","author":"AJ Thompson","year":"2000","unstructured":"Thompson AJ, Montalban X, Barkhof F, Brochet B, Filippi M, Miller DH, Polman CH, Stevenson VL, McDonald WI (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47(6):831\u2013835","journal-title":"Ann Neurol"},{"key":"11077_CR50","first-page":"131","volume-title":"Multiple sclerosis etiology, diagnosis, and new treatment strategies","author":"AC Tselis","year":"2005","unstructured":"Tselis AC, Khan OA (2005) A case for early treatment. Multiple sclerosis etiology, diagnosis, and new treatment strategies. Humana Press, New Jersey, pp 131\u2013144"},{"issue":"1","key":"11077_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/135245850100700107","volume":"7","author":"JS Wolinsky","year":"2001","unstructured":"Wolinsky JS, Narayana PA, Johnson KP, Multiple Sclerosis Study Group and the MRI Analysis Center (2001) United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple sclerosis study group and the MRI analysis center. Mult Scler 7(1):33\u201341. https:\/\/doi.org\/10.1177\/135245850100700107","journal-title":"Mult Scler"},{"key":"11077_CR52","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.meegid.2016.06.022","volume":"43","author":"X Xiang","year":"2016","unstructured":"Xiang X, Guo Y, Yang L, Ge Q, Mijit S, Xu F (2016) Association of human leukocyte antigen DP\/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations. Infect Genet Evol 43:407\u2013411. https:\/\/doi.org\/10.1016\/j.meegid.2016.06.022","journal-title":"Infect Genet Evol"},{"issue":"7","key":"11077_CR53","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jocn.2010.12.022","volume":"18","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, He ZY, Liu HN (2011) Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis. J Clin Neurosci 18(7):933\u2013938. https:\/\/doi.org\/10.1016\/j.jocn.2010.12.022","journal-title":"J Clin Neurosci"},{"issue":"1\u20132","key":"11077_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2009.05.004","volume":"406","author":"M Zivkovi\u0107","year":"2009","unstructured":"Zivkovi\u0107 M, Stankovi\u0107 A, Dinci\u0107 E, Popovi\u0107 M, Popovi\u0107 S, Raicevi\u0107 R, Alavanti\u0107 D (2009) The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Clin Chim Acta 406(1\u20132):27\u201330. https:\/\/doi.org\/10.1016\/j.cca.2009.05.004","journal-title":"Clin Chim Acta"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11077-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11077-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:11:03Z","timestamp":1773396663000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11077-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11077"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11077-4","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Yeditepe University (Date 01.03.2023\/1729).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}